A differentiated approach toward treatment of secondary sulfanilamide resistance
in patients with type 2 diabetes and therapeutic regimens simple enough to be adopted inthe management of the patients under study permit to achieve satisfactory hypoglycemic
effect maintaining an acceptable level of glucose in the blood have been worked out.
